Introduction
For many decades, the adult CNS was considered to have an extremely limited capa city for neuroplasticity and regenera tion. This traditional view has been con siderably revised as it gradually became clear that diseases or injuries can trigger many repair processes in the adult brain, including neuro genesis, axonal sprouting, synapto genesis, angio genesis, oligo dendro genesis and remyelin ation. 1 Although these spontan eous responses may not lead to complete brain repair, 2 the regenerative efforts of the adult CNS provide a novel therapeutic opportunity to boost the res toration of compromised tissue and the neurovascular network. 3, 4 Microglia and macrophages are among the most potent modulators of CNS repair and regeneration; 5 however, these cells are apparently doubleedged swords in the battle for neurological recovery. On the one hand, activated microglia and macrophages promote brain recovery by clearing cell debris, resol ving local inflammation and releasing a plethora of trophic factors. [5] [6] [7] [8] On the other hand, these cells can hinder CNS repair and expand tissue damage. [8] [9] [10] We propose that these seemingly contra dictory functions reflect distinct cellular phenotypes acquired in response to dif ferent micro environ mental cues. In vitro, classically activated (M1) microglia and macrophages release destructive proinflam matory mediators. By contrast, alternatively activated (M2) microglia and macrophages clear cellular debris through phagocyto sis and release numerous protective and trophic factors (Figure 1) . 11, 12 The M1-M2 dichotomy is now rec ognized as an oversimplified concep tual framework that only represents two extreme activation states. The status of microglia and macrophages in vivo is much more complicated than in vitro, and may include a spectrum of different but functionally overlapping phenotypes. For example, a growing body of evidence has revealed diverse M2 phenotype subpopu lations, such as M2a, M2b, M2c and Mox, each with unique physiological features and distinct biological functions. [11] [12] [13] However, the roles of these subpopulations in CNS injuries have not yet been characterized. Nevertheless, the broad M1 and M2 classi fication remains a useful concept in under standing the functional status of microglia and macrophages during CNS injury pro gression, and for exploration of new thera peutic strategies. 11, 14 Emerging evidence now implicates M1-M2 polarization of microglial and/or macrophage populations in several types of acute CNS injury, includ ing stroke, 15 traumatic brain injury (TBI) 16 and spinal cord injury (SCI). 17 A consider able body of literature suggests that acti vated microglia and macro phages with distinct phenotypes promote or interfere with neurological recovery after stroke or other injuries. In particular, the M2 pheno type promotes restorative processes, including neurogenesis, axonal remodel ling, angiogenesis, oligodendrogenesis and remyelination ( Figure 1 ).
In this Perspectives article, we discuss microglial and macrophage phenotypes in the context of CNS remodelling in response to acute injury. Considering these evolu tionarily adaptive functions, we argue that future therapeutic approaches targeting cerebral inflammation will shift from sup pression of all microglia and macrophages to subtle modification of the balance between different phenotypes. We also describe key findings on regulatory mol ecules that control phenotype switchingincluding extra cellular stimulating factors and intracellular signalling moleculeswhich may accelerate the pace of research towards that goal.
Phenotype dynamics
Microglia and macrophages are among the first cells to respond to CNS injuries; they are mobilized within 1 h 18 and continue to accumulate for >1 month. 19 Rather than remaining static at the site of injury, these cells alter their morphology and exert a variety of important functions. In various models of CNS injury, the majority of newly recruited microglia and macrophages at the site of injury express M2 signature genes, whereas cells expressing M1 genes predomi nate by about 1 week after injury. [15] [16] [17] 20 Abstract | The traditional view of the adult brain as a static organ has changed in the past three decades, with the emergence of evidence that it remains plastic and has some regenerative capacity after injury. In the injured brain, microglia and macrophages clear cellular debris and orchestrate neuronal restorative processes. However, activation of these cells can also hinder CNS repair and expand tissue damage. Polarization of macrophage populations toward different phenotypes at different stages of injury might account for this dual role. This Perspectives article highlights the specific roles of polarized microglial and macrophage populations in CNS repair after acute injury, and argues that therapeutic approaches targeting cerebral inflammation should shift from broad suppression of microglia and macrophages towards subtle adjustment of the balance between their phenotypes. Breakthroughs in the identification of regulatory molecules that control these phenotypic shifts could ultimately accelerate research towards curing brain disorders.
macrophages, as well as from the continuing recruitment of proinflammatory M1 cells to the site of injury.
Of note, the M2 to M1 transition occur ring in microglia and macrophages after CNS injuries is distinct from the pheno typic changes observed in macrophages in nonCNS tissues, which usually shift from an initial proinflammatory M1 pheno type towards an inflammationresolving M2 phenotype. 21 The precise reasons for this difference are not yet clear; however, inherent disparities between microglia and macrophages might have a role. 22, 23 In addi tion, the difference might at least partially be attributed to the blood-brain barrier (BBB) and the formation of a glial scar, both of which restrict the recruitment of new M2 macrophages and microglia to the site of injury during the recovery phase. Given the evidence of a beneficial role for M2 microglia and macrophages in CNS regen eration, the M2 to M1 phenotypic switch may create an unfavourable microenviron ment for CNS repair, which is usually fully established by several days after injury and lasts for at least 4 weeks. 24, 25 Microglial and macrophage pheno typic polarization in CNS injury might be affected by many other factors in addition to the elapsed time after injury. For example, microglia and macrophages in the core of the ischaemic zone are phenotypically dif ferent from those in the pen umbra, 15, 20 sug gesting that the severity of injury influences their polarization. In addition, although macrophages and microglia in both white and grey matter exhibit the M2 to M1 switch after injury 16 or with ageing, 26 the temporal pattern of the switch differs in these two tissue types; the most prominent phenotypic changes occur in macrophages and microglia in white matter.
Ageing is another key factor that affects microglial and macrophage phenotypes. 27 The traditional view holds that microglia and macrophages from elderly individu als are primed towards the M1 phenotype, which dictates profound cytotoxicity that contributes to agerelated neuronal defi cits. 27 In 2013, however, this concept was challenged by findings of agerelated micro glial priming towards an M2 phenotype, which was accompanied by downregulation of neurotoxic pathways and upregulation of neuroprotective pathways. 28 Further studies of the effects of ageing on microglial and macrophage polarization will be critical for establishing therapeutic approaches for agerelated injuries such as stroke.
Microglia are the resident macrophages of the brain. Although they share many functions with peripheral macrophages, polarized microglial populations can be distinguished from polarized macrophages by protein expression profiles, phago cytic capacity and response to injuries. 22, 23 Furthermore, M2 microglia seem to be more protective than M2 macrophages in vitro, and show a greater tendency to maintain their M2 status. 22, 23 Validation of these observations in vivo has been challenging owing to the paucity of markers to distin guish microglia from other macro phages. Currently, mouse bone marrow chimaeras, which have wildtype microglia in the brain but green fluor escent protein expressing macrophages in the periphery, are the only available model to address this problem. In vivo studies in such animals have con firmed that both microglia and bone marrow derived macrophages in the CNS are involved in phenotype switching, 8 but may contribute differently to CNS repair. 29 
Functions in brain repair

Neurogenesis
The phenotypes of microglia and macro phages can exert positive or negative effects on adult neurogenesis after injury. For example, M1 activated microglia impair basal neurogenesis. 9, 30 These proinflam matory cells secrete destructive factors that hinder neurogenesis and aggravate long term neurological deficits after injury. 31 By contrast, M2 activated microglia promote basal neurogenesis. 30, 32 Following brain injury, microglia and macrophages that produce specific trophic factors can increase neural precursor cell proliferation, neuro blast migration and functional integration of nascent neurons into existing neural circuitry. 33, 34 this notion, delayed, longterm treatment with minocycline, a selective inhibitor of M1 microglia, 35 promotes neurogenesis and functional recovery after stroke. 10 By contrast, sustained micro glial inhibition by minocycline, beginning immediately after stroke, suppresses neuro genesis. 36 These seemingly conflicting results suggest that M1 microglia also exert some proneuro genic functions-such as clearance of cell debris-early after brain injury, and that future therapeutic strategies may need to target the correct phenotype at the right time to improve stroke outcomes.
Axonal regeneration
In the adult CNS, axonal regeneration after injury occurs to a limited extent. 37 Not sur prisingly, M1 activated microglia and macro phages hinder axonal regeneration. 38, 39 For example, M1 cells activated by lipopolysac charide or IFNγ inhibit neurite outgrowth 39 and induce axonal retraction in dystrophic neurons in vitro. 38 In vivo, macro phage infil tration also correlates with axonal dieback. 38 Although the untimely activation and infil tration of microglia and macrophages might be detrimental to injured axons, M2 macro phages are critical for axonal regeneration. 40 Specialized subsets of these cells that secrete protective molecules, such as IL10 and oncomodulin, promote axonal regrowth and recovery after SCI. 7, 40 Similarly, in the damaged optic nerve, macrophagederived oncomodulin promotes axonal regenera tion. 41, 42 In these axonal regeneration models, macrophages seem to have a dominant role whereas microglia exert minor, if any, effects. 40 These observations demonstrate that macrophages and microglia occupy distinct niches in the injured CNS.
Synaptic plasticity
Microglia also regulate synaptic plasticity, not only during development but also after CNS injuries, 43, 44 and directly modulate synaptic activity. 45, 46 Whether microglial phenotypes differentially affect synapses is still unknown. However, intriguing studies revealed that the complement C1q complex, which can shift microglia toward the pro inflammatory M1 phenotype, regulates synaptic pruning by tagging synapses for microglial phagocytosis. 47, 48 In addition, low levels of tumour necrosis factor (TNF), a classic inflammatory cytokine secreted by M1 effector cells, can promote synaptic connectivity under physiological condi tions. 49 These observations suggest that M1 microglia have an adaptive role in the regulation of synaptic homeostasis and plas ticity. However, it remains to be elucidated whether and how the surge of M1related mediators after CNS injuries influences synapse remodelling.
White matter integrity
Polarized microglia and macrophages have distinct roles in oligodendrocyte renewal and white matter recovery. In models of multiple sclerosis, a switch from M1predominant to M2predominant pheno types was observed at the initi ation of remyelination. 8 Studies of selective depletion of M1 or M2 cells have shown that oligo dendrocyte regenera tion is promoted by the M2 phenotype and impaired by the M1 phenotype. 8 However, the exact function of polarized microglial and macrophage populations in white matter damage and repair after CNS injuries is still unclear.
In TBI, microglia and macrophages undergo an M2 to M1 phenotypic shift in the corpus callosum, the largest white matter structure in the brain, at late stages of injury. 16 Notably, the number of M1 cells in the injured brain strongly correlates with the severity of white matter injury. 16 Several in vitro studies have revealed multitiered effects of polarized microglia and macro phages on oligo dendro cytes. First, specific phenotypic characteristics of microglia and macrophages influence oligodendrocyte survival. In an in vitro model of hypoxia and ischaemia, culture medium conditioned by M1 microglia exacerbated oligodendro cyte death induced by oxygen and glucose deprivation. 16 Second, M1 and M2 micro glia are thought to exert opposing effects on oligodendrogenesis. M1 activated micro glia impair oligodendrocyte formation in a TNFdependent manner, whereas M2 activated microglia support this process, at least in part, through the release of insulin like growth factor I (IGFI). 30 In addition, culture medium conditioned by M2 cells promotes differentiation of oligodendrocyte precursors into mature cells. 8 These findings strongly suggest that microglial and macro phage polarization helps determine oligo dendrocyte fate and white matter integrity after CNS injuries.
Angiogenesis and vascular repair
The proangiogenic function of macrophages in vascular repair during wound healing is well established: 50, 51 M2 macrophages produce proangiogenic factors, such as vascular endothelial growth factor 52 and IL8. 50 These cells also release angiogenic matrix metalloproteinase 9 propeptide in a unique form that is not complexed to tissue inhibitor of metalloproteinases 1. 51 The phenotypespecific roles of microglia in angiogenesis have not yet been elucidated, although the activation state of micro glia is known to regulate brain endothelial cell pro liferation, a key step in both BBB repair and angiogenesis. 53 Interestingly, the M1type cytokine TNF and the M2type cytokine transforming growth factor β (TGFβ) exhibit distinct effects on endo thelial prolif eration. Hence, it is possible that the polari zation state of microglia is a key regulator of angiogenesis and BBB repair after CNS injury. However, the exact role of polari zation in angiogenesis after CNS injuries awaits further investigation.
Summary
The past decade has seen an exponential increase in research supporting the pheno typespecific roles of microglia and macro phages in multiple steps of CNS repair and regeneration. However, these data are mainly based on in vitro experiments or in vivo depletion of such cells and, to date, very little direct in vivo evidence exists for the involvement of microglia and/or macrophages in CNS repair. Advances in imaging methods, however, have provided novel, powerful tools to noninvasively observe microglia and macrophages in live animals (Box 1). [54] [55] [56] Further identification of new in vivo imaging markers for various phenotypes will provide additional insight into the precise role of microglial and macro phage polarization in CNS repair, and may guide future therapeutic interventions targeting phenotype switching.
Modulation of phenotypes
In response to distinct microenvironmental cues, an already fully polarized M1 or M2 subpopulation can reverse its phenotype and function. 57 With increasing numbers of studies confirming the differential contribu tions of M1 and M2 microglia and macro phages to CNS repair, identification of the extracellular signals that trigger pheno typic shifts and the molecular switches that control such a dramatic change may lead to novel therapeutic strategies.
Extracellular signals
Phenotypic shifts can be triggered by molecular cues from injured tissue. 15, 58 For example, levels of extracellular matrix pro teins such as chondroitin sulphate proteo glycans (CSPGs) increase substantially after SCI, thereby promoting M2 macro phage polarization. 58 Inhibition of CSPG production by xyloside immediately after SCI shifts macrophage polarization towards the M1 phenotype, increases tissue loss, and impairs functional motor recovery. Furthermore, conditioned culture medium collected from ischaemic neurons can prime microglial polarization toward the M1 phenotype, 15 suggesting that injured neurons release soluble factors and/or shed specific components to drive the M2 to M1 shift. Compromised brain endo thelial cells also release various cytokines that mediate polarization. 59 In addition, infiltrating peripheral immune cells, particularly T lymphocytes, can interact with micro glia and macrophages, inducing differenti ation to either M1 or M2 phenotypes. 60 For example, in mouse models of amyo trophic lateral sclerosis, passive transfer of regulatory T lymphocytes from mice at an early disease stage into mice with endstage disease results in sustained M2 microglial polarization and prolongs survival, sup porting the importance of antigenspecific regulatory T cells in M2 induction. 60 In general, culture medium conditioned by type 1 Thelper cells, which is abun dant in IFNγ, TNF and IL2, induces M1 polarization. By contrast, culture medium conditioned by type 2 Thelper cells and regulatory T cells, which both secrete IL4, diverts microglial polarization toward the M2 phenotype. 60, 61 T cells can infiltrate the injured CNS and, consequently, it is possi ble that Tcellderived factors drive micro glial and macrophage phenotype changes after CNS injuries. However, the identity of the extracellular signals that induce the phenotypic shift in this setting is not yet clear. Several phenotypic shift indu cers, such as TNF, IFNγ, IL6, neutro phil gelatinaseassociated lipocalin (also known as lipocalin2), TGFβ, galectin1, bone morphogenetic protein 7, substance P and IL25, [62] [63] [64] [65] [66] [67] are expressed in the CNS and may be upregulated after injury (Figure 2 ). It is possible that several of these molecules work synergistically or differentially at specific times after CNS injury to regulate phenotypic shifts.
Intracellular molecular switches
Breakthrough research on macrophages has revealed several transcriptional regu lators that serve as central switches to turn on subsets of M1 or M2 genes and thereby promote polarization (Figure 2) . The signal transducer and activator of transcription (STAT) family of transcrip tion factors have crucial roles in cytokine and immune regulation. In general, STATs are activated by Janus kinases (JAKs) and suppressed by suppressor of cytokine sig nalling (SOCS) proteins. Many members of the STAT family, including STAT1, STAT3 and STAT6, are involved in phenotypic switching of micro glia and macrophages. 68 For example, STAT1 increases M1 polari zation after IFNγ exposure, 69 and STAT6 is important in establishing the M2 pheno type on IL13 and IL4 stimulation. 70, 71 The functions of STAT3 are diverse, involving both IL10stimulated M2 polarization 72 and IL6stimulated M1 polarization. 73 In addition to these cytokines, other factors, such as haem oxygenase 1 and HDL, influ ence macrophage phenotype through the SOCS-JAK-STAT pathway. 74, 75 The nuclear hormone receptor per oxisome proliferatoractivated receptor γ (PPARγ) is another transcription factor that has long been known to modulate micro glial and macrophage phenotypes. PPARγ mediates monocyte differentiation into macrophages primed toward M2 polariza tion, which have antiinflammatory prop erties. 76 As one might expect, the PPARγ agonists rosiglitazone and pioglitazone are capable of indu cing M2 phenotypic switching in models of CNS diseases related to inflammation. 77, 78 Several discoveries highlight the impor tance of other transcription factors in pheno type modulation. For example, differ ent subtypes of interferon regulatory factors (IRFs) exert distinct roles in macrophage polarization: IRF4 is a key transcrip tion factor controlling M2 polarization, 79 whereas IRF5 and IRF8 control M1 polari zation. 80, 81 In mice, CCAAT/enhancer binding protein β also induces expression of M2macrophagespecific genes, such as Arg1 and Il10. 82 Further characterization of these factors and their signalling pathways may provide an exciting array of potential therapeutic targets for CNS recovery.
Other research in the past 5 years has defined a role for microRNAs (miRNAs) in polarization of microglia and macrophages (Figure 2) . 83, 84 M1 and M2 phenotypes are associated with distinct miRNA profiles. 83 For example, miRNA155 expression pro motes M1 polarization by silencing mRNAs transcribed from M2 signature genes, 85, 86 whereas miRNA124 promotes M2 polari zation by targeting mRNA transcribed from M1 genes. 87 With the fast pace of miRNA research, increasing numbers of miRNAs are being associated with specific microglial and macrophage phenotypes. 88, 89 However,
Box 1 | Techniques for in vivo imaging of microglia and macrophages
Advances in the field of in vivo imaging provide novel opportunities to noninvasively monitor the highly dynamic transformations of microglia and macrophages and track their interactions with surrounding cells and structures. These imaging approaches may enable direct observation of the involvement of microglia and macrophages in CNS repair processes and correlation of morphological changes with cellular behaviour in an intact environment.
Two-photon fluorescence microscopy ■ In the CNS, this moderately noninvasive technique achieves an imaging resolution of ~200 μm ■ Combined with expression of fluorescent proteins in microglia and macrophages, as well as other CNS cells, two-photon microscopy enables investigation of the role of microglia and macrophages in specific repair processes PET ■ PET has exceptional sensitivity despite its relatively low resolution (1-3 mm) ■ Radiolabelled ligands that specifically bind to the translocator protein can be used (most commonly the isoquinoline carboxamide derivative 11 C-PK-11195) ■ PK-11195 has a high affinity for activated microglia and macrophages in several brain injury models, including cerebral ischaemia and traumatic brain injury ■ Other translocator-protein-specific ligands have been proposed for in vivo imaging, but require further investigation ■ Several advantages of PET, including its noninvasiveness, ease of application in humans and quantitative properties, make it an ideal imaging tool to measure microglial and macrophage behaviour in vivo MRI ■ MRI offers high spatial resolution (~50 μm) ■ The technique utilizes the propensity of microglia and macrophages to phagocytose small particles; iron oxide nanoparticles and ultrasmall superparamagnetic particles are most widely used because they are particularly attractive for mononuclear phagocytes ■ As an alternative to 1 H, nanoparticles containing other isotopes (for example, 19 F) exhibit improved signal specificity owing to the absence of background signals in the body further studies are required to confirm the specific functions of these miRNAs in phenotype switching.
Our current knowledge about the intra cellular molecules that regulate phenotype switching is mainly derived from studies in peripheral macrophages. The impor tance of these molecules in microglial and macrophage polarization after CNS inju ries has not been verified. Nevertheless, several reports have documented changes in expression of these switch molecules and their possible involvement in CNS injuries (Table 1) . For example, in mice, expres sion of Irf8 gradually decreases within 3 days after stroke, whereas expression of Irf4 increases. 90, 91 Such trends are consist ent with the peak in M2 cells 3-5 days after stroke. 15 Furthermore, Irf8 knockout pro tects mice against ischaemic brain injury and ameliorates inflammation after stroke. 91 Although these two studies focused on the roles of neuronal IRF4 and IRF8, it is possible that the expression of these two molecules in microglia and macrophages regulates the phenotypes of these cells. This concept would explain, at least in part, the detrimental and protective changes after stroke observed in Irf4-knockout and Irf8 knockout mice, respectively. In addition, some chemicals that can regulate pheno typic switches (for example, miRNA124, PPARγ and STAT1) have been shown to determine injury outcomes through microglia related and/or macrophage related mechanisms. 78, 92, 93 Further studies of the roles of these molecules in micro glial and macrophage polarization after CNS injuries and their involvement in CNS repair are warranted.
Therapeutic perspectives
Our rapidly expanding knowledge of microglial and macrophage phenotypes offers novel therapeutic approaches to CNS remodelling. As M2 phenotypes promote regeneration, transplantation of ex vivo activated M2 cells to counteract the M2 to M1 shift observed at late stages after CNS injuries is a promising cellbased regen erative strategy. However, one animal study demonstrated that administration of M2 macrophages at subacute stages after middle cerebral artery occlusion failed to improve stroke outcomes after 2 weeks. 94 Although no firm conclusions can be drawn from this study, owing to the lack of a dose-response curve and longterm end points, the results raise several important questions about the possible therapeutic applications of M2 microglia and macrophages. What is the optimal route of administration? When should the cells be administered? Is CNS penetration essential for therapeutic effects? An additional concern is that microglia and macrophages are highly sensitive and may encounter unexpected extracellular cues during cell preparation and after transplan tation, resulting in reduction or loss of their protective M2 features. The application of genetically engineered, instead of ex vivo induced, M2 cells might help to solve this problem. Comprehensive animal studies are required to determine the clinical potential of such cellular therapy, although the vast majority of studies to date support the ben efits of a carefully timed M1 to M2 shift. 8, 78 For example, transplantation of M2 cells was effective in promoting neurological recovery in a rat model of multiple sclerosis. 95 The tissueprotective factors produced by M2 microglia and macrophages represent additional opportunities to increase our armamentarium of restorative treatments ( Table 2 ). Many of these factors, such as IGFI and oncomodulin, have already dem onstrated efficacy in various models of CNS injury. 41, 96 Of course, the application of a single protective factor cannot fully repli cate the beneficial effects of M2 cells, which involve the additive or synergistic actions of multiple protective molecules. In this regard, the identification of extracellular signals and intracellular molecular switches that control phenotypic changes provide two promising methods for regenerative therapies involving microglia and/or macrophages.
The first approach is to either turn on the molecular switch toward M2 activation, or turn off the switch toward M1 activa tion. For example, nanoparticledelivered small interfering RNAs can silence IRF5 in macro phages and improve the repair of myocardial infarcts and cutaneous wounds. 97, 98 As some nanomaterials cross the BBB with ease, this approach is a prom ising option for delivery of phenotype switching molecules to injured CNS tissue. In addition, inhibitors and inducers of key switch molecules have been identified that provide additional strategies for interven tion. 77, 99 Therapies that target phenotype related miRNAs or inhibitors of these miRNAs are also under development. For example, cationic liposomes can be used to deliver miRNAs into macrophages. 87 The utility of this approach in CNS injuries depends on the capability of such liposomes to penetrate the compromised BBB.
The second approach to phenotype reg ulation involves supplementing the micro environment with M2stimulating factors. For example, IL4 is effective in reducing acute ischaemic brain damage. 100 As this molecule has strong M2inducing proper ties, its effect on longterm recovery after CNS injury deserves further investigation. In addition, lentiviral delivery of M2 indu cers, such as IL10, into microglia and/or macrophages may induce M2 polarization and prevent the M2 to M1 phenotypic shift in inflammatory environments. 101 Although phenotypic modulation of microglia and macrophages seems to be a promising way to promote CNS regenera tion, translation of these approaches to the clinic is a daunting task because our knowl edge of the dynamics of micro glial and macrophage polarization and the result ing phenotypes is still incomplete. Further charac terization of the phenotypic behav iour of these cells, especially its temporal and spatial evolution, will be critical in deciding between possible therapeutic regimens. Furthermore, the action of many phenotype inducers is not a simple 'allornone' phe nomenon, but a function of timing and dose. An instructive example of the additional challenges lying ahead is offered by CSPGs, which have both protective and destructive properties in injured tissue. Although CSPGs can induce an M1 to M2 phenotypic switch during acute phases of SCI, they are a major component of scar tissue and their presence hinders axonal regeneration. 58 Caution against eliciting a poorly timed M1 to M2 phenotype switch in the clinic is advised, because additional beneficial roles for M1 microglia may yet be discovered. It is unlikely that mammals evolved an M1 phenotype that only serves to exacerbate injury and has no positive role whatso ever. For example, as mentioned above, M1 microglia seem to contribute to synaptic remodelling and may also drive the clear ance of cellular debris early after acute brain injuries. In addition, several factors that are important in CNS repair, such as MMP9, 102 can be released not only from M2 cells, but also from M1 microglia and macrophages. 103 In this context, both pro inflammatory and inflammationresolving cells might be important for effective tissue repair at different time points after CNS Oncomodulin Promotes neurite growth from DRG or RG neurons tMCAO in spontaneously hypertensive rat 115 Osteopontin Attracts lateral migration of neuroblasts from the ipsilateral subventricular zone to the ischaemic striatum Optic nerve cell culture 32 Trypsin-2 Promotes generation of neurons from optic nerve cells
Abbreviations: BDNF, brain-derived neurotrophic factor; DRG, dorsal root ganglion; GDNF, glial cell-line-derived neurotrophic factor; IGF-I, insulin-like growth factor I; NPC, neural precursor cell; RG, retinal ganglion; SDF-1, stromal cell-derived factor 1; tMCAO, transient middle cerebral artery occlusion.
injuries. Another potential concern is that the longterm maintenance of M2 pheno types may negatively affect immune defence and result in serious adverse effects, such as tumorigenesis. 104 We must, therefore, be careful to boost the correct phenotype at the right time to improve natural repair processes after CNS injuries.
Finally, we must concede that most of our knowledge on microglia and macro phage polarization is derived from rodents. Unfortunately, rodent immune cells exhibit many differences from their human counter parts. 105 Although some in vitro studies suggest that polarization of human micro glia and macrophages might resemble that in rodent cells, 23 whether all the features of polarization in rodent cells are truly appli cable to humans remains an important question. Additional studies using human biological systems, 105 such as induced pluri potent stem cells, will be essential for translation of microglial and macrophage phenotype research into clinical practice.
